ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO088

JNK Signalling Mediates Oxidant-Induced Tubular Epithelial Cell Death

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Grynberg, Keren, Department of Nephrology, Monash Medical Centre, Monash, Victoria, Australia
  • Tesch, Gregory H., Department of Nephrology, Monash Medical Centre, Monash, Victoria, Australia
  • Ozols, Elyce, Department of Nephrology, Monash Medical Centre, Monash, Victoria, Australia
  • Mulley, William R., Department of Nephrology, Monash Medical Centre, Monash, Victoria, Australia
  • Nikolic-Paterson, David J., Department of Nephrology, Monash Medical Centre, Monash, Victoria, Australia
  • Ma, Frank Yuanfang, Department of Nephrology, Monash Medical Centre, Monash, Victoria, Australia
Background

The reactive oxygen species-inducible JNK signaling pathway is activated in tubular cells within 20min of renal ischaemia/reperfusion (I/R) injury. Tubular cell death following I/R injury is reduced by systemic JNK inhibitor treatment, but whether this is a direct or indirect effect and the contribution of JNK1 versus JNK2 isoforms are unclear. We aimed to define the role of JNK1 versus JNK2 signaling in oxidant-induced tubular cell death and whether this mechanism also operates in diabetes.

Methods

Bilateral renal I/R injury was induced in groups (n=8 to 10) of male wild type (WT), Jnk1-/-, Jnk2-/-, and Jnk1f/f γGT-Cre mice (all C57BL/6J) which were killed 24hr later. Diabetes was induced in WT mice by 5 low dose streptozotocin (STZ) injections.

Results

Compared to renal I/R injury in WT mice, Jnk1-/- but not Jnk2-/- mice were significantly protected from tubular cell death (PAS and cleaved caspase 3 staining) and renal failure (serum creatinine) (both P<0.01). Furthermore, conditional deletion of Jnk1 in proximal tubular cells (Jnk1f/f γGT-Cre mice) also showed a significant reduction in tubular cell death and renal failure (both P<0.01 vs WT I/R). H2O2 (0.25 to 1mM) induced dose-dependent cell death in primary cultures of WT tubular epithelial cells (TEC); however, Jnk1-/- TEC showed 50%↓ cell death (P<0.001), whereas Jnk2-/- TEC showed no protection. A JNK inhibitor reduced H2O2-induced cell death in WT and Jnk2-/- TEC by 50%, but did not affect cell death in Jnk1-/- TEC. In a further study, renal I/R injury was induced in WT mice 8 weeks after STZ-induced diabetes. Compared to non-diabetic controls, I/R injury caused increased JNK signalling, greater tubular cell death and more severe renal failure (all P<0.01 vs non-diabetic I/R). Culture of WT TEC in high glucose for 48hr increased H2O2-induced cell death. However, a JNK inhibitor reduced H2O2-induced cell death under high glucose by 38 to 45% (P<0.001).

Conclusion

JNK1 but not JNK2 direct contributes to oxidant-induced tubular cell death in vivo and in vitro. JNK signalling may also promote the enhanced tubular cell death and renal failure seen in renal I/R injury in established diabetes.